Form 10-Q UNITED THERAPEUTICS Corp For: Jun 30
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140729/A8AYO22C8Z22G2ZA22JS2CZZAJ2CZ2R2Z262
Filed on: July 29, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA accepts United Therapeutics' sNDA for Tyvaso to treat IPF
- Power Metallic Defines High-Grade Maiden Resource at Lion Averaging ~3.9% CuEq, with >85% Indicated and Significant Expansion Potential
- BioNxt Advances Sublingual Everolimus ODF for Organ Transplant Rejection with Initiation of Large-Animal Pharmacokinetic Study
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
